Novartis to Build Radioligand Therapy Manufacturing Plant in Denton, Texas
Novartis announced plans to establish a 46,000-square-foot radioligand therapy manufacturing site in Denton, Texas, as part of its $23 billion US expansion. The facility is expected to be operational in 2028.